Extension of Time to File SOU

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 10/31/2017)

---

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 10/31/2017)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: AILERON
SERIAL NUMBER: 85566635

The applicant, Aileron Therapeutics, Inc., having an address of
      281 Albany Street
      Cambridge, Massachusetts 02139
      United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/25/2012.

For International Class 005:
Current identification: pharmaceutical compositions, namely, preparations for the treatment of obesity, cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; reagents for use in biological processing for medical purposes

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development



A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements may jeopardize the validity of the form or any resulting registration, declares that he/she is properly authorized to execute this form on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.


Signature: /D. Allen Annis/      Date Signed: 09/19/2013
Signatory's Name: D. Allen Annis
Signatory's Position: Vice President, Biophysical & Analytical Technologies
Signatory's Phone: Not Required

RAM Sale Number: 85566635
RAM Accounting Date: 09/19/2013

Serial Number: 85566635
Internet Transmission Date: Thu Sep 19 12:30:47 EDT 2013
TEAS Stamp: USPTO/ESU-XXX.XX.XX.X-201309191230478420
26-85566635-50088925010ce1b2061d9a6e9ff9
fe2c7353e92668e22d1f20d6efe06b23dcbbd3-D
A-13411-20130918183712244998